首页> 外国专利> TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER

TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER

机译:1型组织金属蛋白酶(TIMP-1)的组织抑制剂作为癌症先兆的最小残留病或复发病的癌症标志物和术后复发标志物

摘要

The present invention describes a method for determining whether an individual is suffering from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual. The present invention furthermore describes a method for determining whether an individual is suffering from minimal residual disease or recurrent cancer after being treated for the primary cancer by determining a parameter representing the post-operative TIMP-1 concentration in body fluid samples from the individual. In addition, the invention describes the additive effect of combined post-operative measurements of plasma TIMP-1 and serum CEA.
机译:本发明描述了一种通过确定代表来自个体的体液样品中TIMP-1浓度的参数来确定个体是否患有癌症的方法。本发明还描述了一种方法,该方法用于通过确定代表来自个体的体液样品中的术后TIMP-1浓度的参数来确定个体在接受原发性癌症治疗后是否正在遭受最小程度的残留疾病或复发性癌症。另外,本发明描述了血浆TIMP-1和血清CEA的联合术后测量的累加作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号